We are live on ! Find out more
PODD icon

Insulet

203 hedge funds and large institutions have $4.34B invested in Insulet in 2017 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 72 increasing their positions, 58 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

193% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 15

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

25% more capital invested

Capital invested by funds: $3.46B → $4.34B (+$879M)

24% more repeat investments, than reductions

Existing positions increased: 72 | Existing positions reduced: 58

17% more funds holding

Funds holding: 174203 (+29)

14% more call options, than puts

Call options by funds: $3.19M | Put options by funds: $2.81M

0.11% less ownership

Funds ownership: 108.19%108.08% (-0.11%)

Holders
203
Holders Change
+29
Holders Change %
+16.67%
% of All Funds
4.6%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.09%
New
44
Increased
72
Reduced
58
Closed
15
Calls
$3.19M
Puts
$2.81M
Net Calls
+$380K
Net Calls Change
-$734K
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$593M +$22.7M +345,350 +4%
Capital Research Global Investors
2
Capital Research Global Investors
California
$393M -$21.5M -327,733 -5%
Primecap Management
3
Primecap Management
California
$342M -$361K -5,500 -0.1%
Vanguard Group
4
Vanguard Group
Pennsylvania
$333M +$5.19M +79,064 +2%
Wellington Management Group
5
Wellington Management Group
Massachusetts
$327M -$112M -1,710,512 -26%
BlackRock
6
BlackRock
New York
$268M -$6.39M -97,303 -2%
FCM
7
Frontier Capital Management
Massachusetts
$145M +$41M +624,465 +42%
ClearBridge Investments
8
ClearBridge Investments
New York
$135M +$20K +304 +0%
FAM
9
Fred Alger Management
New York
$125M +$29.1M +443,970 +33%
D.E. Shaw & Co
10
D.E. Shaw & Co
New York
$92.7M +$11.1M +169,377 +14%
State Street
11
State Street
Massachusetts
$91.2M +$9.9M +150,912 +13%
Lord, Abbett & Co
12
Lord, Abbett & Co
New Jersey
$81.1M +$14.2M +216,628 +23%
CIP
13
Champlain Investment Partners
Vermont
$74.3M -$641K -9,760 -0.9%
Millennium Management
14
Millennium Management
New York
$65M +$37.5M +571,082 +154%
JP Morgan Chase
15
JP Morgan Chase
New York
$54.2M +$11.5M +174,520 +29%
Northern Trust
16
Northern Trust
Illinois
$52.6M -$322K -4,904 -0.6%
Wells Fargo
17
Wells Fargo
California
$51.9M -$5.98M -91,074 -11%
DM
18
Deerfield Management
New York
$48.7M +$13.7M +208,573 +42%
TI
19
Think Investments
California
$47.7M
Norges Bank
20
Norges Bank
Norway
$47M -$8.24M -125,552 -16%
Renaissance Technologies
21
Renaissance Technologies
New York
$45.6M +$33.3M +506,800 +328%
ACH
22
ArrowMark Colorado Holdings
Colorado
$43.1M -$808K -12,309 -2%
Balyasny Asset Management
23
Balyasny Asset Management
Illinois
$39.8M +$24.4M +371,703 +181%
SPC
24
Slate Path Capital
New York
$39M -$141M -2,155,000 -79%
Loomis, Sayles & Company
25
Loomis, Sayles & Company
Massachusetts
$38M -$341K -5,196 -0.9%

PODD Hedge Fund Activity: Q4 2017 in Review

203 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Insulet (PODD) for Q4 2017, worth a combined $4.34B — up 25% from $3.46B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new PODD positions and 15 closed out — a net gain of 29 holders — while 72 added to existing stakes and 58 trimmed.

The largest buyer was Frontier Capital Management, adding an estimated $41M. The largest seller was Slate Path Capital, cutting an estimated $141M.

  • 203 institutional investors held Insulet (PODD) as of Q4 2017, up from 174 in Q3 2017.
  • Funds reported $4.34B of Insulet stock for Q4 2017, up 25% quarter-over-quarter.
  • 44 funds opened new Insulet positions in Q4 2017 and 15 closed out, a net change of +29 holders.
  • The largest Insulet buyer in Q4 2017 was Frontier Capital Management, an estimated $41M added.
  • The largest Insulet seller in Q4 2017 was Slate Path Capital, an estimated $141M sold.

Based on aggregated 13F filings for Q4 2017.